Financial Data and Key Metrics Changes - The company ended Q2 2025 with cash and short-term investments totaling $991 million, having closed the first $250 million tranche from Toyota and received an additional $41 million through its ATM facility [27] - The Q2 2025 net loss was $325 million, which includes a $168 million operating loss and a $157 million non-operating loss, primarily due to non-cash items [28] - Adjusted EBITDA for Q2 was a loss of $132 million, reflecting an increase in spending compared to the previous quarter [29] Business Line Data and Key Metrics Changes - The company reported significant progress in flight testing, completing 76 flights in July alone, which is crucial for certification efforts [6] - The company is 70% complete on the Joby side and over 50% complete on the FAA side for stage four of certification, up 10 points from the previous quarter [7] Market Data and Key Metrics Changes - The company is witnessing a global regulatory momentum, with the U.S. government and other countries streamlining international validation of FAA type certification for eVTOL aircraft [9] - The acquisition of Blade's passenger business is expected to accelerate readiness for commercial eVTOL operations globally, including in key markets like Dubai [13] Company Strategy and Development Direction - The company aims to leverage the acquisition of Blade to enhance its operational capabilities and expand its route maps, thereby increasing margins and operational tempo [15] - The company is pursuing three paths to commercialization: owned and operated service, direct sales, and regional partnerships [16] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the regulatory environment and the company's ability to scale production capacity to meet demand [20] - The company is focused on methodical scaling, disciplined capital management, and translating technical progress into long-term value [26] Other Important Information - The company is expanding its production capabilities, with plans to double its production capacity to 24 aircraft per year at its Marina facility and eventually produce up to 500 aircraft per year [22] - The company is also developing a hybrid variant of its existing aircraft for defense applications, with flight tests expected to start in the fall [19] Q&A Session Summary Question: Plans for providing eVTOLs to local charter operators post-Blade acquisition - The company prefers retaining long-term cash flow from passenger service but sees value in Blade's asset-light model for flexibility [36] Question: Specifications of the TIA aircraft being constructed - The TIA aircraft is nearly identical to previous models, with FAA oversight during the build process [39] Question: Initial commercial service plans in the U.S. post-Blade acquisition - The acquisition enhances operations in New York, allowing for faster ramp-up due to existing infrastructure and customer base [44] Question: Remaining steps for type certification - The company is 70% complete on stage four, with the remaining steps expected to be completed over the next year [48] Question: Timeline for the Blade acquisition to impact financials - The acquisition is in the process of closing, with contributions expected in the fourth quarter [83]

Financial Data and Key Metrics Changes - The company announced a sale of the Blade passenger business to Joby Aviation for up to $125 million, which is expected to create long-term value for stakeholders [6][9] - Medical revenue grew 17.6% year-over-year to a record $45.1 million in Q2 2025, driven by new transplant center customers and increased demand [18][26] - Adjusted EBITDA margin for the medical segment rose to 13.4% in Q2 2025, compared to 11.4% in Q1 2025, but declined from 14.4% in Q2 2024 [18][20] Business Line Data and Key Metrics Changes - The medical business accounted for approximately 60% of revenue in 2024, up from 12% in 2020, and contributed about 85% of the segment's adjusted EBITDA [6][9] - The passenger business saw a 5.5% decrease in short-distance revenue year-over-year, primarily due to lower revenue in the US segment [20] - The passenger segment adjusted EBITDA tripled year-over-year from $800,000 to $2.4 million, driven by improved flight margins and lower SG&A expenses [22] Market Data and Key Metrics Changes - The company exited the Canadian market in August 2024, impacting short-distance revenue in the US [20] - European operations showed strong revenue growth due to realignment with local partners and operational changes [21] Company Strategy and Development Direction - The company aims to focus on its medical division as a standalone entity, which will be renamed Strata Critical Medical, emphasizing its growth potential in the medical sector [6][9] - A disciplined capital allocation strategy is planned, supported by approximately $200 million in cash from the passenger business sale [12][26] - The company is entering a long-term partnership with Joby Aviation to access eVTOL aircraft for medical use, enhancing its service offerings [15][32] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the growth prospects of the medical business, expecting mid-teens revenue growth in the second half of 2025 [26] - The company anticipates improved fleet uptime and adjusted EBITDA margins in the medical segment, projecting margins of approximately 15% [26] - Management noted that the divestiture is expected to be neutral to adjusted EBITDA and free cash flow on a go-forward basis [25][26] Other Important Information - The company ended the quarter with no debt and $113.4 million in cash and short-term investments [25] - The financial impact of the divestiture is expected to be adjusted EBITDA and free cash flow neutral, supported by estimated corporate cost efficiencies of $7 million [10][25] Q&A Session Summary Question: What are the current priorities for capital allocation post-transaction? - Management highlighted opportunities in M&A and organic growth, emphasizing the need for capital to scale the business effectively [29][30] Question: Are there any operational impacts from the divestiture on the medical segment? - Management stated that the company is set up for success as a standalone entity and expects the partnership with Joby to add significant value [32][33] Question: Why was the passenger business sold now? - Management indicated that the market was discounting the value of the passenger business, and the divestiture allows for a clearer focus on the high-growth medical segment [37][38] Question: What is the growth outlook for the medical business? - Management expressed optimism about organic growth driven by new technologies and services, aiming for high teens adjusted EBITDA margins in the long term [41][43] Question: How is the business trending quarter to date? - Management reported strong performance in July, with no signs of seasonal slowdown yet [44] Question: What are the tax implications of the transaction? - Management noted that they have enough NOLs to offset capital gains from the divestiture, expecting minimal cash tax impact [46]

Core Viewpoint - Joby Aviation has signed a Memorandum of Understanding (MoU) with Abdul Latif Jameel (ALJ) to establish a significant electric aircraft presence in Saudi Arabia, indicating strong market entry potential and investor enthusiasm [2][10]. Group 1: Partnership Details - The MoU outlines plans for Joby to deliver up to 200 eVTOL aircraft to Saudi Arabia, with an estimated deal value of approximately $1 billion [2]. - ALJ, a well-established Saudi conglomerate, has a strong operational presence and has been a key partner for Joby, having invested in its Series C funding round [2][7]. - The agreement includes establishing a distribution network, launching local air taxi services, developing maintenance services, and creating pilot training initiatives [2][10]. Group 2: Market Reaction - Joby shares surged over 14% in premarket trading following the MoU announcement but experienced a reversal during regular trading, attributed to profit-taking and short selling [1][6]. - The stock price forecast indicates a potential upside of 8.01%, with an average target of $8.67 based on analyst ratings [5]. Group 3: Recent Achievements - The MoU follows a series of positive developments for Joby, including a $250 million investment from Toyota and significant progress in FAA certification [9][4]. - Joby has achieved crucial flight testing milestones, demonstrating operational maturity and enhancing investor confidence [9][4]. Group 4: Strategic Implications - The partnership with ALJ aligns with Joby's strategy of leveraging local expertise for international expansion, facilitating quicker market entry and revenue generation [2][7]. - This collaboration supports Saudi Arabia's Vision 2030 goals for economic diversification and new mobility solutions, positioning Joby as a key player in the region [2][3].